Cogent Biosciences (COGT) Treasury Shares (2017 - 2025)
Cogent Biosciences' (COGT) quarterly Treasury Shares came in at $539000.0 in Q4 2025, up 573.75% year-on-year from $80000.0 in Q4 2024, and up 573.75% on a QoQ basis from $80000.0 in Q4 2024.
Cogent Biosciences (COGT) Treasury Shares (2017 - 2025) Analysis & Trends
Cogent Biosciences (COGT) has 9 years of Treasury Shares data on file, last reported at $539000.0 in Q4 2025.
- On a quarterly basis, Treasury Shares rose 573.75% year-over-year to $539000.0 in Q4 2025; TTM through Dec 2025 was $539000.0, a 573.75% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, up 47.02% from the prior year.
- Treasury Shares for Q4 2025 stood at $539000.0, up from $80000.0 in the prior quarter.
- Over the last five years, Treasury Shares for COGT reached as high as $2.5 million in Q4 2023 and fell as low as $80000.0 in Q4 2024.
- Historically, Treasury Shares has averaged $454754.5 across 5 years, with a median of $103289.0 in 2021.
- Across the five-year window, Treasury Shares sank 96.8% in 2024 and soared 573.75% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $103289.0 in 2021, then slipped by 7.7% to $95334.0 in 2022, then surged by 2522.36% to $2.5 million in 2023, then sank by 96.8% to $80000.0 in 2024, then surged by 573.75% to $539000.0 in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $539000.0 in Q4 2025, $80000.0 in Q4 2024, and $2.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 539,000.00 |
| Dec 31, 2025 | 539,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 2.50 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Mar 31, 2022 | 95,334.00 |
| Mar 31, 2022 | 95,334.00 |
| Dec 31, 2021 | 103,289.00 |
| Dec 31, 2021 | 103,289.00 |
| Sep 30, 2021 | 103,289.00 |
| Sep 30, 2021 | 103,289.00 |
| Jun 30, 2021 | 103,289.00 |
| Jun 30, 2021 | 103,289.00 |
| Mar 31, 2021 | 113,835.00 |
| Mar 31, 2021 | 113,835.00 |
| Dec 31, 2020 | 132,244.00 |
| Dec 31, 2020 | 132,244.00 |
| Sep 30, 2020 | 163,325.00 |
| Sep 30, 2020 | 163,325.00 |